Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
Clinical trial NCT03573986 · TERMINATED
Trial details
- NCT number
- NCT03573986
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2020-01-14
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.